HomeINMB • NASDAQ
add
INmune Bio Inc
Previous close
$7.69
Day range
$7.53 - $7.75
Year range
$6.50 - $14.74
Market cap
151.34M USD
Avg Volume
191.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 14.00K | -63.16% |
Operating expense | 11.03M | 70.73% |
Net income | -11.02M | -68.68% |
Net profit margin | -78.75K | -357.85% |
Earnings per share | -0.61 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 26.00M | -49.02% |
Total assets | 46.83M | -36.69% |
Total liabilities | 17.81M | -4.67% |
Total equity | 29.02M | — |
Shares outstanding | 19.78M | — |
Price to book | 4.90 | — |
Return on assets | -53.05% | — |
Return on capital | -64.40% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -11.02M | -68.68% |
Cash from operations | -7.48M | -555.21% |
Cash from investing | — | — |
Cash from financing | -2.50M | — |
Net change in cash | -9.85M | -756.17% |
Free cash flow | -3.58M | -498.91% |
About
Founded
2015
Headquarters
Website
Employees
14